相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis
Radha K. Dhiman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Albumin in decompensated cirrhosis: new concepts and perspectives
Mauro Bernardi et al.
GUT (2020)
Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy
Fei-Pi Lin et al.
HEPATOLOGY (2020)
Lessons from real life experience of rifaximin use in the management of recurrent hepatic encephalopathy
Fiona Chautant et al.
WORLD JOURNAL OF HEPATOLOGY (2020)
Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy
Samuel Selorm Fiati Kenston et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis
Tatsunori Hanai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathy
Hiroyuki Suzuki et al.
HEPATOLOGY RESEARCH (2019)
Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy
Silvia Nardelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
Zhaohui Bai et al.
AGING-US (2019)
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
Mark Hudson et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2019)
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
Zhida Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients
Atsushi Hiraoka et al.
LIVER CANCER (2019)
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis
Christian Labenz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
Zhaohui Bai et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
Shinya Nishida et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United Kingdom
Ellen Berni et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis
Elliot B. Tapper et al.
HEPATOLOGY (2018)
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial
Kazuyuki Suzuki et al.
HEPATOLOGY RESEARCH (2018)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Paolo Caraceni et al.
LANCET (2018)
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
Guy Neff et al.
PHARMACOECONOMICS (2018)
Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients
Hiroko Setoyama et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2017)
Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy
Barjesh Chander Sharma et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding
Qiuhe Wang et al.
JOURNAL OF HEPATOLOGY (2017)
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
Hiroki Nishikawa et al.
HEPATOLOGY RESEARCH (2016)
A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis
Oliviero Riggio et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy
Kevin D. Mullen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Human serum albumin, systemic inflammation, and cirrhosis
Vicente Arroyo et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases
JOURNAL OF HEPATOLOGY (2014)
Hepatic Encephalopathy Is Associated With Significantly Increased Mortality Among Patients Awaiting Liver Transplantation
Robert J. Wong et al.
LIVER TRANSPLANTATION (2014)
A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
Barjesh Chander Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Antibiotics for the treatment of hepatic encephalopathy
Kavish R. Patidar et al.
METABOLIC BRAIN DISEASE (2013)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora
S. M. Finegold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines
Christopher Randolph et al.
LIVER INTERNATIONAL (2009)
Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory
M. Odeh
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, doubledummy, controlled clinical trial
A Mas et al.
JOURNAL OF HEPATOLOGY (2003)
分享论文
